Ultra-sensitive CAR T cells eliminate hard-to-treat tumours in mice
Nature
by Felicity NelsonFebruary 26, 2026
A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen. A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.
Verticals
scienceresearch
Originally published on Nature on 2/26/2026